About Pharmaceutical Press

Our publishing roots go back to 1841, a time when many medical professional bodies felt chemists and druggists were untrained and unregulated. Jacob Bell, a respected chemist and heir to his father’s successful pharmacy, along with William Allen, a scientist and owner of a pharmaceutical company, encouraged other chemists and druggists to form an alliance.

Together they founded the Pharmaceutical Society of Great Britain (PSGB), a professional organisation to represent and protect the interests of the profession. Bell armed with wealth and literary talent and keen to promote the Society, launched and edited the Pharmaceutical Journal. Considered one of the few ‘class’ periodicals of its time, this enduring publication continues to connect pharmacists and champion the profession.

In 1842, Queen Victoria grants PSGB a Royal Charter of Incorporation, ensuring legal authority to recommend bills to parliament and enforce regulations.

In the 1850s the PSGB began publishing reference books, and by 1909 Pharmaceutical Press had been established.

In 1933 the PSGB purchased the rights to produce and sell the Extra Pharmacopoeia, as it was no longer a one-man job for William Martindale, the son of the original author, also called William Martindale and a Council member of the PSGB. The resource, now known as Martindale: The Complete Drug Reference continues to be valued as the most comprehensive and practical reference source about drugs and medicines.

After the Second World War, in 1949 the PSGB and the British Medical Association took the war formulary and continued to publish it for general use as British National Formulary, the first choice for concise medicines information. This remains a key part of the healthcare infrastructure in the UK, has worldwide recognition and an enduring relationship with the National Health Service.

Stockley’s Drug Interactions, edited by Dr Ivan Stockley launched in 1981 to help health professionals quickly and reliably decide the best course of action when managing the use of drug combinations. When the task grew and became too much for one person to manage, the PSGB was considered its natural home and it joined the publishing portfolio entrenching its reputation as the most indispensable source of drug interaction information available.

During this period, the importance of characterisation of the excipients used in dosage forms became an increasingly critical factor for consideration, leading to a thirst for knowledge and information in this area. A collaboration between the PSGB and the American Pharmaceutical Association Academy of Pharmaceutical Research and Science was set up, leading to the publication of the first edition of the Handbook of Pharmaceutical Excipients in 1986.

Soon after in 1988, the PSGB was granted permission to use the Royal designation by Queen Elizabeth II and became the Royal Pharmaceutical Society of Great Britain (RPSGB). A number of years later in 2010 for transparency and accountability, regulatory powers of the RPSGB were transferred to the General Pharmaceutical Council (GPhC) and the Royal Pharmaceutical Society (RPS) became the new professional leadership body for pharmacists in England, Scotland and Wales.

The Pharmaceutical Press publishing portfolio continued to grow from strength to strength, and in 2004 MedicinesComplete was launched, an online platform providing quick and easy access to knowledge products and tools at the point of care. With the added benefit of having the information regularly updated.

Reflecting Pharmaceutical Press’s status as the Royal Pharmaceutical Society’s knowledge business, a new brand strategy was launched to make it easier for health professionals to recognise the essential products and services most valuable to them.

After 30 years at the helm Stephen Bazire asked Pharmaceutical Press to carry on his legacy to ensure Psychotropic Drug Directory continued to be an essential reference for clinical decision-making in mental health services. The respected guidance was added to MedicinesComplete enabling more frequent updates to the resource.

Research conducted by Imperial College showed an 83% reduction in prescribing errors, as a result of Dosium’s Touchdose solution’s real-time link to BNF and BNFC, tackling medication errors at their source, saving valuable time and significantly improving patient safety.

Continuing our commitment to patient safety and innovation.